Summary

Report Summary

Revance Therapeutics Inc. Strategic SWOT, PESTLE Analysis Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Operational KPI’s and Recent Trends Report is a comprehensive and easily accessible overview of Revance Therapeutics Inc.'s business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Revance Therapeutics Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Revance Therapeutics Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Revance Therapeutics Inc.'s overall strategic standing and supports informed decision-making and strategic planning. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Revance Therapeutics Inc. enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Revance Therapeutics Inc. is a biotechnology company founded in 1999 and headquartered in Nashville, Tennessee, USA. The company focuses on science driven innovation across aesthetics, consumer skincare, and therapeutic medicine. Revance operates primarily in the United States while expanding its commercial footprint through strategic partnerships and product distribution channels. Revance is best known for its flagship neuromodulator DAXXIFY, a daxibotulinumtoxinA lanm injection approved for the temporary improvement of moderate to severe glabellar lines and for the treatment of cervical dystonia in adults. DAXXIFY represents a long duration botulinum toxin innovation designed to deliver extended efficacy compared with conventional treatments. The company also exclusively distributes the Teoxane RHA Collection of resilient hyaluronic acid fillers in the US market, broadening its presence in facial aesthetics. Its business segments include Aesthetics, Consumer Skincare, and Therapeutics. The aesthetics portfolio addresses facial wrinkles, folds, and contouring, while therapeutics focuses on neuromuscular conditions. Supported by robust research and development and a growing commercial infrastructure, Revance continues to position itself as an innovation led player serving healthcare providers and patients across generations.

Revance Therapeutics Inc. in the News:-

2025-05-27 - Revance Announces CEO Transition
2025-05-23 - Revance Names New CEO to Drive Next Phase in Aesthetic Innovation
2025-03-31 - Crown Laboratories Now Operates Under the Name Revance
2025-02-06 - Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Revance Therapeutics Inc.'s internal and external factors through SWOT analysis, PESTLE analysis and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Revance Therapeutics Inc.:
• Revance Therapeutics Inc. Value Chain Analysis
• Revance Therapeutics Inc. Porter's Five Forces Analysis
• Revance Therapeutics Inc. VRIO Analysis
• Revance Therapeutics Inc. BCG Analysis
• Revance Therapeutics Inc. Segmentation, Targeting and Positioning (STP) Analysis
• Revance Therapeutics Inc. Ansoff Matrix Analysis

ページTOPに戻る

Table of Contents

Tables 5
Charts 6
Revance Therapeutics Inc. - Key Company Facts 7
Revance Therapeutics Inc. - Company Description 8
Revance Therapeutics Inc. - Top Executives 9
Revance Therapeutics Inc. - Head Office & Locations 10
Head Office - Country 10
Revance Therapeutics Inc. - Products and Services 11
Products 11
Services 12
Revance Therapeutics Inc. - Corporate Strategy 13
Revance Therapeutics Inc. - Business Description 16
Aesthetics 16
Consumer Skincare 17
Therapeutics 17
Revance Therapeutics Inc. - ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 21
Revance Therapeutics Inc. - SWOT Analysis 22
Overview 22
Strengths 24
Weaknesses 27
Opportunities 28
Threats 30
Revance Therapeutics Inc. - PESTLE Analysis 31
Overview 31
Political Factors 33
Economic Factors 35
Social Factors 37
Technological Factors 39
Legal Factors 41
Environmental Factors 43
Competing Players 45
Snapshot of Competing Players 46
AbbVie Inc 46
Key Company Facts 46
Company Description 46
AbbVie Inc - SWOT Spotlight 47
AbbVie Inc - PESTLE Spotlight 49
Key Financials 51
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 51
Key Financial Ratio Analysis 56
Ipsen SA 58
Key Company Facts 58
Company Description 58
Key Financials 59
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 59
Key Financial Ratio Analysis 64
Galderma SA 66
Key Company Facts 66
Company Description 66
Merz Pharma GmbH and Co KGaA 67
Key Company Facts 67
Company Description 67
Evolus Inc 68
Key Company Facts 68
Company Description 68
Key Financials 69
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 69
Key Financial Ratio Analysis 74
Revance Therapeutics Inc. - In the News 76
27-May-2025- Revance Announces CEO Transition 76
23-May-2025- Revance Names New CEO to Drive Next Phase in Aesthetic Innovation 77
31-Mar-2025- Crown Laboratories Now Operates Under the Name Revance 77
06-Feb-2025- Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics 79
Appendix 80
Definitions 80
SWOT Analysis 80
PESTLE Analysis 80
Value Chain Analysis 80
ESG Spotlight 80
Research Methodology 81
Disclaimer 82
Contact Us 82